BRUKER CORPORATION Payments of Financing Costs
BRUKER CORPORATION (BRKR) reported Payments of Financing Costs of $5.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2025-03-03
- BRUKER CORPORATION payments of financing costs for the quarter ending 2024-12-31 was $0.00.
- BRUKER CORPORATION payments of financing costs for the quarter ending 2024-09-30 was $0.00.
- BRUKER CORPORATION payments of financing costs for the quarter ending 2024-06-30 was $800.00K.
- BRUKER CORPORATION payments of financing costs for the quarter ending 2024-03-31 was $4.70M.
- BRUKER CORPORATION payments of financing costs for fiscal 2024 was $5.50M.
- BRUKER CORPORATION payments of financing costs for fiscal 2023 was $0.00.
- BRUKER CORPORATION payments of financing costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- BRUKER CORPORATION payments of financing costs for fiscal 2021 was $100.00K, a 0.00% change from fiscal 2020.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $800.00K derived: sum of 3 quarters · filed 2025-03-03 | $5.50M 10-K · filed 2025-03-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $800.00K derived: sum of 2 quarters · filed 2024-11-07 | $5.50M 10-Q · filed 2024-11-07 | $5.50M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $5.50M 10-Q · filed 2024-08-09 | $5.50M derived: sum of 3 quarters · filed 2025-03-03 | $5.50M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | $4.70M 10-Q · filed 2024-05-10 | $4.70M derived: sum of 2 quarters · filed 2025-03-03 | $4.70M derived: sum of 3 quarters · filed 2025-03-03 | $4.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 | |||
| 2021-12-31 | $100.00K 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $100.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $100.00K 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $4.40M 10-K · filed 2022-02-28 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $0.00 derived: sum of 3 quarters · filed 2015-02-27 | $1.40M 10-K · filed 2015-02-27 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $1.40M 10-Q · filed 2013-11-08 | $1.40M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.40M 10-Q · filed 2013-08-08 | $1.40M derived: sum of 3 quarters · filed 2014-02-27 | $1.50M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $1.40M 10-Q · filed 2013-05-09 | $1.40M derived: sum of 2 quarters · filed 2014-02-27 | $1.50M derived: sum of 3 quarters · filed 2014-02-27 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $100.00K derived: sum of 2 quarters · filed 2014-02-27 | $1.30M 10-K · filed 2014-02-27 | |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $1.30M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $1.20M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |